Standigm
standigm.com
Actively hiring
As featured in
Follow
Overview
News
Technologies
Salaries
Products
People
Growth
Financials
Overview
Standigm is a Seoul company founded in 2015 that builds an automated workflow for drug discovery. Its platform selects targets, generates candidate molecules and prioritises them for synthesis with robotic laboratory support. The company partners with pharmaceutical firms and runs its own pipeline of small molecule programmes.
News
Standigm and Institut Pasteur Korea Identify Drug Candidates for Resistant Tuberculosis Thanks to Right Foundation Grant
Read more
Report
Standigm Signs MOU with Merck Korea for AI drug Discovery Research
--Standigm Inc., the leading workflow artificial intelligence drug discovery company, today announced the signing of a Memorandum of Understanding with Merck Korea, for AI-based drug discovery research. "Candidate chemical discovery using AI technology fo
Read more
Report
Standigm signs MOU with Institut Pasteur Korea for AI-based drug discovery research on infectious disease
Read more
Report
Standigm established a synthetic research center to improve efficiency of AI drug discovery
Read more
Report
Standigm Expands Global Footprints with New Office in Cambridge, UK
/PRNewswire/ -- Standigm, a leading workflow AI drug discovery company, today announced the opening of a new office in Cambridge, United Kingdom ("UK"), to...
Read more
Report
Pro access
Upgrade to see all 8 mentions
Upgrade to a paid plan to read every media mention of this company - funding news, awards, product launches and press releases from all the outlets writing about it.
Every media mention and press release
Funding news, awards and product launches
Fresh coverage from every outlet writing about the company
Upgrade now
Cancel anytime. Secure checkout. Instant activation.